<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T01:45:51Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/32203" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/32203</identifier><datestamp>2026-09-24T04:47:46Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Lawrence, Mbuagbaw</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Anni, Naharin Sultana</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Global Health</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2025-08-22T19:31:52Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2025-08-22T19:31:52Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/32203</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/21466</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Background&#xd;
Human papillomavirus (HPV) is the most common sexually transmitted infection &#xd;
worldwide, responsible for a rising burden of cancer and disease in both women and men. &#xd;
Despite the proven effectiveness of HPV vaccination, uptake and awareness lag far behind &#xd;
global targets, particularly among men and in low- and middle-income countries (LMICs). &#xd;
Persistent gaps in knowledge, attitudes, and practices (KAP) undermine public health efforts &#xd;
and perpetuate global inequities in HPV prevention. This dissertation conducts a &#xd;
comprehensive, multi-method investigation of KAP related to HPV and its vaccine among &#xd;
men, mapping global disparities and identifying barriers and facilitators.&#xd;
Methods&#xd;
We adopted a “sandwich” structure, integrating three original studies. First, we conducted a &#xd;
systematic review and meta-analysis of 590 studies to synthesize KAP and HPV vaccine &#xd;
uptake by age, sex, region, and country income level. Second, we conducted a cross sectional survey among Canadian men aged 16 and older to evaluate KAP regarding HPV &#xd;
and its vaccine, and to identify factors influencing KAP in a high-income setting. Third, we &#xd;
conducted a qualitative descriptive study with men, healthcare providers, and policymakers &#xd;
in Bangladesh to gain an in-depth understanding of men's KAP regarding HPV and its &#xd;
vaccine and to identify sociocultural and systemic barriers and facilitators affecting vaccine &#xd;
acceptance in a low- and middle-income context. All studies were guided by the Health &#xd;
Belief Model, providing a unifying theoretical framework for analysis across diverse &#xd;
populations.&#xd;
&#xd;
Results&#xd;
We found substantial global disparities in HPV knowledge and vaccine uptake. Both men &#xd;
and women in low- and middle-income countries exhibited significantly lower knowledge&#xd;
and vaccination coverage compared to those in high-income settings, with younger age &#xd;
groups and males generally having lower KAP levels. We identified key barriers including &#xd;
doubt about HPV vaccine effectiveness, financial constraints, and inadequate access to &#xd;
healthcare services and social, cultural or religious stigma. We observed persistent gaps in &#xd;
HPV-related KAP among men in Canada, primarily due to limited knowledge, insufficient &#xd;
healthcare provider recommendation, and perceived lack of personal risk, even within a &#xd;
well-resourced health system. In contrast, we found a very low knowledge specifically HPV &#xd;
vaccine, widespread misconceptions, sociocultural stigma, lack of research and exclusion of &#xd;
men from vaccination programs to be major barriers to HPV vaccine acceptance and uptake&#xd;
among Bangladeshi men.&#xd;
Conclusions&#xd;
Eliminating global disparities in HPV prevention demands context-specific strategies: in &#xd;
high-income countries like Canada, strengthening healthcare provider engagement and &#xd;
reducing financial barriers are critical to closing persistent gaps in male vaccination; in low and middle-income countries, expanding vaccine access, providing male-focused education, &#xd;
and integrating gender-neutral policies are urgently needed. Implementing these context specific, evidence-based strategies is essential to achieving equitable HPV prevention on a &#xd;
global scale.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">Human papillomavirus (HPV) is a common sexually transmitted infection that can lead to &#xd;
several types of cancer in both women and men. Although there is a safe and effective &#xd;
vaccine to prevent HPV, many people, especially men and those in lower-income countries, &#xd;
know little about the virus or the vaccine, and very few get vaccinated. This research set out &#xd;
to understand why.&#xd;
We combined results from 590 studies around the world and conducted new research in &#xd;
Canada and Bangladesh to find out what people know about HPV, how they feel about the &#xd;
vaccine, and what stops them from getting it. Our results show that people in low- and&#xd;
middle-income countries, and men everywhere, are less likely to know about HPV and are &#xd;
less likely to get vaccinated. Some of the main reasons are a lack of information, financial &#xd;
barriers, social stigma, and limited access to healthcare.&#xd;
Many men are still unaware of the risks of HPV or the benefits of the vaccine in Canada, &#xd;
even though the healthcare system is strong. On the other hand, men in Bangladesh are &#xd;
facing additional challenges, like cultural stigma and not being included in national &#xd;
vaccination programs. Our research highlights the need for better education, easier access to &#xd;
the vaccine, and health policies that include everyone, especially men, in efforts to prevent &#xd;
HPV. Addressing these gaps can help save lives and reduce inequalities in health around the &#xd;
world.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Human papillomavirus (HPV), HPV vaccine, Knowledge, Attitude, Practice, Global HPV Vaccine uptake, HPV Prevention, Men</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">KNOWLEDGE, ATTITUDES, AND PRACTICES TOWARD  HUMAN PAPILLOMAVIRUS (HPV) AND ITS VACCINE</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>